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F. tularensis is a poorly understood category A priority pathogen and the etio-
logical agent of Tularemia, or rabbit fever. Previous work by coworkers at
LLNL identified seven putative virulence factor proteins, for which most
have weak homology to proteins of known function. These seven proteins pre-
sumably are secreted host effector proteins, as they are important for inducing
an encysted morphology in F. tularensis infected amoeba. Subsequent genetic
studies have further implicated some of these ORFs as having a role in infection
of human cells in culture. We have applied a structural-functional genomics
approach in an attempt to elucidate the function of these rapid encystment
proteins (REPs). Here we present the crystal structures of REP24 (24 kD)
and REP34 (34 kD) and report on their putative function. REP24 appears to
be a cysteine protease with a novel arrangement of the active-site catalytic
triad, and we show that it binds to the cysteine protease inhibitor, JPM-565,
both in vitro and in crystallo. REP34 By structural homology and, REP34
appears to be a Zn-dependent carboxypeptidase that possesses a novel fold
that deviates from related funnelins, resulting in a rearranged active and
substrate-recognition sites. We show the definitive presence of a Zn by anom-
alous diffraction, and catalytic activity of the enzyme using hippuryl-L-Arg.
We believe that these structures provide potential starting points for rational
design of new therapeutics against tularemia and, combined with further
biochemical evidence, will provide important insights into the molecular mech-
anisms of F. tularensis infection.
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Virulence and biofilm formation are among a number of processes in Vibrio
cholerae controlled by the quorum-sensing master regulator HapR. The crystal
structure of HapR revealed it to be a member of the TetR family of transcription
factors with an N terminal helix-turn-helix DNA binding domain and a C ter-
minal dimerization domain. An inactive variant of HapR was found to contain a
glycine to aspartic acid substitution at position 39 within the N-terminal hinge
region. Size exclusion chromatography and circular dichroism revealed no sig-
nificant structural differences between the normal and variant HapR. However,
structural reconstruction using small/wide angle x ray scattering data suggested
that the arrangement of the DNA binding domains of the variant HapR was
altered. To gain further insight into the functional role of the N terminal hinge
region of HapR and the structural consequences of a substitution of aspartic
acid for glycine at position 39, we have solved the crystal structure of the
variant HapR to 2.3 A˚.
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Skeletal muscle myosin class II proteins are molecular machines that convert
the chemical energy derived from the hydrolysis of ATP into mechanical
work used to power muscle contraction. The three-dimensional structure of
the truncated head from an embryonic body wall myosin isoform (EMB) of
the common fruit fly, Drosophila melanogaster, is reported at 2.2 A˚ resolution.
The histidine-tagged recombinant protein was expressed in and purified from
the indirect flight muscles of an engineered fly line (Caldwell et al., Methods,
2012). The purified histidine-tagged EMB myosin retains ATPase activity
similar to that of the untagged EMB isoform. EMB myosin subfragment 1
(S1), contains the myosin heavy chain motor domain (MD) and the essential
light chain (ELC). Crystals of the complex belong to space group P212121
with the unit cell parameters of a = 108.5 A˚, b = 148.5 A˚, and c = 148.7 A˚.Two copies of the molecule were resolved in the asymmetric unit and these
have slight conformational differences. Interestingly, a number of the domains
encoded by alternative exons are in contact between the two molecules, sug-
gesting potential isoform-specific interactions that may be relevant in vivo.
While the nucleotide-binding site had some ligand electron density, the ligand
was not resolved. The enzymatic conformational state of the myosin cross-
bridge cycle was determined as post-rigor by comparisons with known myosin
structures. Amino acid residue orientations are currently being compared
between EMB S1 and other myosins, particularly in the alternatively-
encoded regions, to gain insights into structure-function relationships that
define isoform-specificity.
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Histone variant H2A.Z-containing nucleosomes exist at most eukaryotic pro-
moters and play important roles in gene transcription and genome stability.
The multi-subunit nucleosome-remodeling enzyme complex SWR1, conserved
from yeast to mammals, catalyzes the ATP-dependent replacement of histone
H2A in canonical nucleosomes with H2A.Z. The over-incorporation of H2A.Z
in chromatin, however, is associated with breast cancer, and therefore H2A.Z
and p400/SRCAP are targets for cancer therapy. How SWR1 catalyzes the
replacement reaction is largely unknown. Here we determined the crystal struc-
ture of the region (599-627) of the catalytic subunit Swr1, termed Swr1-Z
domain, N-terminal to the ATPase domain, in complex with the H2A.Z-H2B
dimer at 1.78 A˚ resolution. The Swr1-Z domain forms a 3(10) helix and an
irregular chain, separated by an 8-residue disordered loop. Swr1-Z forms hydro-
phobic interactions with the a3 and aC helices of H2A.Z, and also with the a1 and
a2 helices of H2B. Importantly, a conserved LxxLF motif in the Swr1-Z specif-
ically recognizes the aC helix of H2A.Z, which leads to an extension of two
helical turns of the aC helix in H2A.Z. Additionally, the Asp-rich region in
Swr1-Z forms electrostatic interactions with Arg85 in the L2 loop, and with
Arg89 in the a3 helix of H2A.Z, and with Lys60 in the a2 helix of H2B, which
makes the complex more stable. Furthermore, in vitro studies show that Swr1-Z
domain can deliver the H2A.Z-H2B dimer to the DNA-(H3-H4)2 tetrasome to
form the nucleosome by a histone chaperone mechanism, and in vivo studies
indicate that Swr1-Z has an important functional role. Our results provide the
first structural insights into how Swr1 recognizes H2AZ-H2B, and help identify
similar binding regions between human H2AZ-H2B and p400/SRCAP, paving
the road for structure-based cancer drug design.
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The Gram-positive pathogen Staphylococcus aureus is a leading cause of global
morbidity and mortality. Like many multi-drug resistant organisms, S. aureus
contains antibiotic modifying enzymes that facilitate resistance to a multitude
of antimicrobial compounds. FosB is aMn2þ-dependent fosfomycin-inactivating
enzyme found in S. aureus that catalyzes nucleophillic addition of either
L-cysteine (L-Cys) or bacillithiol (BSH) to the antibiotic resulting in a modified
compound with no bacteriacidal properties. The three-dimensional x-ray crystal
structure of FosBSa has been determined to a resolution of 1.15 A˚. Co-
crystallization of FosBSa with either L-cys or BSH results in an unnatural disul-
fide bond between the exogenous thiol and the active site Cys9 of the enzyme.
Two crystals of FosBSa contain Zn2þ in the active site, but subsequent kinetic
analyses indicated that the enzyme is inhibited by Zn2þ for L-Cys transferase
activity and only marginally active for BSH transferase activity. Fosfomycin-
treated disk diffusion assays involving S. aureus Newman and the USA300
methicillin-resistant S. aureus (MRSA) demonstrate a marked increase in sensi-
tivity of the organism to the antibiotic in either the BSH or FosB null strains, indi-
cating that both are required for survival of the organism when treated with
fosfomycin. This work identifies FosB as the sole fosfomycin-modifying
pathway of S. aureus and establishes the enzyme as a potential therapeutic target
for increased efficacy of the antibiotic against the pathogen.
